RARE Q1 2026 Earnings WiderthanExpected Loss Highlights Cost Pressures Ernexa Therapeutics Q3 2023 Earnings Losses Deepen as Stock Declines No Revenue Reported CTO Q1 2026 Earnings Massive EPS Surprise of 374 as FFO Exceeds Expectations DOO Q1 2026 Earnings EPS Surprise of 796 Lifts Shares Orion SA OEC Q1 2026 Earnings A Miss on EPS Weighs on Performance but Shares Rally Strategy Inc STRF Q1 2026 Earnings Preferred Stock Reports Massive Miss as EPS Deeply Negative